$AISF Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PLURISTEM THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PLURISTEM THERAPEUTICS INC. Get notifications about new insider transactions in PLURISTEM THERAPEUTICS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16 2015 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.13 | 10,000 | 21,300 | 20,000 | 10 K to 20 K (+100.00 %) |
| Sep 16 2015 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.07 | 10,000 | 20,700 | 10,000 | 0 to 10 K |
| Jun 30 2015 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | President, COO, CFO | Grant | A | 0.00 | 200,000 | 0 | 1,301,616 | 1.1 M to 1.3 M (+18.16 %) |
| Jun 30 2015 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 200,000 | 0 | 1,968,298 | 1.8 M to 2 M (+11.31 %) |
| Jan 08 2015 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Grant | A | 0.00 | 49,000 | 0 | 162,750 | 113.8 K to 162.8 K (+43.08 %) |
| Jan 08 2015 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Grant | A | 0.00 | 49,000 | 0 | 271,964 | 223 K to 272 K (+21.98 %) |
| Jan 08 2015 | AISF | PLURISTEM THERAPEU ... | Kwiat Moria | Director | Grant | A | 0.00 | 35,000 | 0 | 107,500 | 72.5 K to 107.5 K (+48.28 %) |
| Jan 08 2015 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Grant | A | 0.00 | 48,000 | 0 | 339,135 | 291.1 K to 339.1 K (+16.49 %) |
| Jan 08 2015 | AISF | PLURISTEM THERAPEU ... | BRAUN ISAAC | Director | Grant | A | 0.00 | 35,000 | 0 | 335,208 | 300.2 K to 335.2 K (+11.66 %) |
| Jan 08 2015 | AISF | PLURISTEM THERAPEU ... | MERETZKI HAVA | Director | Grant | A | 0.00 | 35,000 | 0 | 335,208 | 300.2 K to 335.2 K (+11.66 %) |
| Jan 08 2015 | AISF | PLURISTEM THERAPEU ... | SHORRER DORON | Director | Grant | A | 0.00 | 49,000 | 0 | 521,208 | 472.2 K to 521.2 K (+10.38 %) |
| Jan 08 2015 | AISF | PLURISTEM THERAPEU ... | Gur-Lavie Boaz | Chief Financial Off ... | Grant | A | 0.00 | 48,332 | 0 | 107,560 | 59.2 K to 107.6 K (+81.60 %) |
| Nov 12 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.65 | 6,500 | 17,225 | 1,768,298 | 1.8 M to 1.8 M (+0.37 %) |
| Nov 12 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.62 | 6,500 | 17,030 | 1,761,798 | 1.8 M to 1.8 M (+0.37 %) |
| Nov 12 2014 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | COO & President | Buy | P | 2.64 | 6,000 | 15,840 | 1,101,616 | 1.1 M to 1.1 M (+0.55 %) |
| Nov 12 2014 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | COO & President | Buy | P | 2.59 | 5,000 | 12,950 | 1,095,616 | 1.1 M to 1.1 M (+0.46 %) |
| Sep 23 2014 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | COO & President | Grant | A | 0.00 | 11,499 | 0 | 11,499 | 0 to 11.5 K |
| Sep 23 2014 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | COO & President | Buy | P | 2.95 | 11,000 | 32,450 | 1,090,616 | 1.1 M to 1.1 M (+1.02 %) |
| Sep 23 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.92 | 5,000 | 14,600 | 1,755,298 | 1.8 M to 1.8 M (+0.29 %) |
| Sep 22 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.97 | 2,500 | 7,425 | 1,750,298 | 1.7 M to 1.8 M (+0.14 %) |
| Sep 22 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.94 | 2,500 | 7,350 | 1,747,798 | 1.7 M to 1.7 M (+0.14 %) |
| Sep 18 2014 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Buy | P | 2.84 | 2,500 | 7,100 | 319,806 | 317.3 K to 319.8 K (+0.79 %) |
| Sep 18 2014 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Buy | P | 2.80 | 2,500 | 7,000 | 317,306 | 314.8 K to 317.3 K (+0.79 %) |
| Sep 17 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.84 | 15,000 | 42,600 | 1,745,298 | 1.7 M to 1.7 M (+0.87 %) |
| Sep 17 2014 | AISF | PLURISTEM THERAPEU ... | Gur-Lavie Boaz | Chief Financial Off ... | Buy | P | 2.75 | 1,250 | 3,438 | 59,228 | 58 K to 59.2 K (+2.16 %) |
| Sep 16 2014 | AISF | PLURISTEM THERAPEU ... | Gur-Lavie Boaz | Chief Financial Off ... | Buy | P | 2.84 | 3,478 | 9,878 | 57,978 | 54.5 K to 58 K (+6.38 %) |
| Sep 16 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.80 | 15,000 | 42,000 | 1,730,298 | 1.7 M to 1.7 M (+0.87 %) |
| Sep 16 2014 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | COO & President | Buy | P | 2.85 | 10,000 | 28,500 | 1,079,616 | 1.1 M to 1.1 M (+0.93 %) |
| Jun 19 2014 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Sell | S | 3.15 | 5,000 | 15,750 | 291,135 | 296.1 K to 291.1 K (-1.69 %) |
| Jun 19 2014 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Sell | S | 3.13 | 5,000 | 15,665 | 296,135 | 301.1 K to 296.1 K (-1.66 %) |
| Jun 19 2014 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Sell | S | 3.13 | 10,715 | 33,538 | 301,135 | 311.9 K to 301.1 K (-3.44 %) |
| Jun 19 2014 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Sell | S | 3.10 | 22,500 | 69,840 | 311,850 | 334.4 K to 311.9 K (-6.73 %) |
| Mar 05 2014 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Sell | S | 4.02 | 67,858 | 272,789 | 334,350 | 402.2 K to 334.4 K (-16.87 %) |
| Feb 26 2014 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Sell | S | 4.00 | 45,000 | 180,000 | 222,964 | 268 K to 223 K (-16.79 %) |
| Feb 12 2014 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Sell | S | 4.02 | 35,000 | 140,840 | 267,964 | 303 K to 268 K (-11.55 %) |
| Feb 06 2014 | AISF | PLURISTEM THERAPEU ... | Gur-Lavie Boaz | CFO | Grant | A | 0.00 | 27,500 | 0 | 54,500 | 27 K to 54.5 K (+101.85 %) |
| Jan 21 2014 | AISF | PLURISTEM THERAPEU ... | Kwiat Moria | Director | Sell | S | 4.51 | 8,700 | 39,272 | 72,500 | 81.2 K to 72.5 K (-10.71 %) |
| Jan 21 2014 | AISF | PLURISTEM THERAPEU ... | Kwiat Moria | Director | Sell | S | 4.51 | 3,800 | 17,130 | 81,200 | 85 K to 81.2 K (-4.47 %) |
| Jan 21 2014 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 4.51 | 24,900 | 112,399 | 314,806 | 339.7 K to 314.8 K (-7.33 %) |
| Jan 21 2014 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 4.51 | 10,725 | 48,338 | 339,706 | 350.4 K to 339.7 K (-3.06 %) |
| Jan 14 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 4.30 | 67,850 | 291,484 | 1,715,298 | 1.8 M to 1.7 M (-3.81 %) |
| Jan 14 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 4.25 | 2,000 | 8,500 | 1,783,148 | 1.8 M to 1.8 M (-0.11 %) |
| Jan 14 2014 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | CFO, Executive Vice ... | Sell | S | 4.30 | 67,850 | 291,484 | 1,069,616 | 1.1 M to 1.1 M (-5.97 %) |
| Jan 14 2014 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | CFO, Executive Vice ... | Sell | S | 4.25 | 2,000 | 8,500 | 1,137,466 | 1.1 M to 1.1 M (-0.18 %) |
| Jan 14 2014 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 4.30 | 24,373 | 104,706 | 350,431 | 374.8 K to 350.4 K (-6.50 %) |
| Jan 14 2014 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 4.25 | 2,080 | 8,840 | 374,804 | 376.9 K to 374.8 K (-0.55 %) |
| Jan 09 2014 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | CFO, Executive Vice ... | Sell | S | 4.25 | 150 | 638 | 1,139,466 | 1.1 M to 1.1 M (-0.01 %) |
| Jan 09 2014 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | CFO, Executive Vice ... | Sell | S | 4.25 | 30,000 | 127,500 | 1,139,616 | 1.2 M to 1.1 M (-2.56 %) |
| Jan 09 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 4.25 | 150 | 638 | 1,785,148 | 1.8 M to 1.8 M (-0.01 %) |
| Jan 09 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 4.25 | 30,000 | 127,500 | 1,785,298 | 1.8 M to 1.8 M (-1.65 %) |
| Jan 09 2014 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 4.25 | 9,172 | 38,981 | 376,884 | 386.1 K to 376.9 K (-2.38 %) |
| Jan 09 2014 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 4.09 | 14,375 | 58,794 | 386,056 | 400.4 K to 386.1 K (-3.59 %) |
| Jan 09 2014 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 4.09 | 21,250 | 86,913 | 400,431 | 421.7 K to 400.4 K (-5.04 %) |
| Dec 26 2013 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 150,000 | 0 | 1,815,298 | 1.7 M to 1.8 M (+9.01 %) |
| Dec 26 2013 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | CFO, Executive Vice ... | Grant | A | 0.00 | 150,000 | 0 | 1,169,616 | 1 M to 1.2 M (+14.71 %) |
| Dec 26 2013 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Grant | A | 0.00 | 50,000 | 0 | 302,964 | 253 K to 303 K (+19.77 %) |
| Dec 26 2013 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Grant | A | 0.00 | 65,000 | 0 | 402,208 | 337.2 K to 402.2 K (+19.28 %) |
| Dec 26 2013 | AISF | PLURISTEM THERAPEU ... | Kwiat Moria | Director | Grant | A | 0.00 | 35,000 | 0 | 85,000 | 50 K to 85 K (+70.00 %) |
| Dec 26 2013 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Grant | A | 0.00 | 50,000 | 0 | 421,681 | 371.7 K to 421.7 K (+13.45 %) |
| Dec 26 2013 | AISF | PLURISTEM THERAPEU ... | BRAUN ISAAC | Director | Grant | A | 0.00 | 35,000 | 0 | 300,208 | 265.2 K to 300.2 K (+13.20 %) |
| Dec 26 2013 | AISF | PLURISTEM THERAPEU ... | MERETZKI HAVA | Director | Grant | A | 0.00 | 35,000 | 0 | 300,208 | 265.2 K to 300.2 K (+13.20 %) |
| Dec 26 2013 | AISF | PLURISTEM THERAPEU ... | SHORRER DORON | Director | Grant | A | 0.00 | 50,000 | 0 | 472,208 | 422.2 K to 472.2 K (+11.84 %) |
| Nov 12 2013 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Sell | S | 3.29 | 22,244 | 73,183 | 252,964 | 275.2 K to 253 K (-8.08 %) |
| Nov 12 2013 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Sell | S | 3.26 | 45,000 | 146,700 | 275,208 | 320.2 K to 275.2 K (-14.05 %) |
| Sep 16 2013 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 3.05 | 1,000 | 3,050 | 371,681 | 372.7 K to 371.7 K (-0.27 %) |
| Sep 16 2013 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 3.05 | 1,000 | 3,050 | 372,681 | 373.7 K to 372.7 K (-0.27 %) |
| Sep 16 2013 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 3.05 | 42,827 | 130,622 | 373,681 | 416.5 K to 373.7 K (-10.28 %) |
| Sep 16 2013 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 3.23 | 7,173 | 23,169 | 416,508 | 423.7 K to 416.5 K (-1.69 %) |
| Jun 27 2013 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Grant | A | 0.00 | 85,000 | 0 | 320,208 | 235.2 K to 320.2 K (+36.14 %) |
| Jun 27 2013 | AISF | PLURISTEM THERAPEU ... | Kwiat Moria | Director | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Jun 27 2013 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Grant | A | 0.00 | 50,000 | 0 | 337,208 | 287.2 K to 337.2 K (+17.41 %) |
| Jun 27 2013 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Grant | A | 0.00 | 85,000 | 0 | 423,681 | 338.7 K to 423.7 K (+25.10 %) |
| Jun 27 2013 | AISF | PLURISTEM THERAPEU ... | BRAUN ISAAC | Director | Grant | A | 0.00 | 50,000 | 0 | 265,208 | 215.2 K to 265.2 K (+23.23 %) |
| Jun 27 2013 | AISF | PLURISTEM THERAPEU ... | MERETZKI HAVA | Director | Grant | A | 0.00 | 50,000 | 0 | 265,208 | 215.2 K to 265.2 K (+23.23 %) |
| Jun 27 2013 | AISF | PLURISTEM THERAPEU ... | SHORRER DORON | Director | Grant | A | 0.00 | 85,000 | 0 | 422,208 | 337.2 K to 422.2 K (+25.21 %) |
| Jun 27 2013 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 350,000 | 0 | 1,665,298 | 1.3 M to 1.7 M (+26.61 %) |
| Jun 27 2013 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | CFO, Executive Vice ... | Grant | A | 0.00 | 250,000 | 0 | 1,019,616 | 769.6 K to 1 M (+32.48 %) |
| May 21 2013 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 3.01 | 5,129 | 15,438 | 338,681 | 343.8 K to 338.7 K (-1.49 %) |
| May 21 2013 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 3.01 | 18,800 | 56,588 | 343,810 | 362.6 K to 343.8 K (-5.18 %) |
| May 21 2013 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Buy | P | 3.05 | 50,000 | 152,500 | 362,610 | 312.6 K to 362.6 K (+15.99 %) |
| May 21 2013 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Buy | P | 3.00 | 13,902 | 41,706 | 312,610 | 298.7 K to 312.6 K (+4.65 %) |
| May 21 2013 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 3.06 | 21,500 | 65,790 | 298,708 | 320.2 K to 298.7 K (-6.71 %) |
| Mar 25 2013 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Option Exercise | M | 0.62 | 27,500 | 17,050 | 0 | |
| Mar 25 2013 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Buy | M | 0.62 | 27,500 | 17,050 | 320,208 | 292.7 K to 320.2 K (+9.40 %) |
| Aug 21 2012 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 5.00 | 33,853 | 169,265 | 1,315,298 | 1.3 M to 1.3 M (-2.51 %) |
| Aug 21 2012 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | Chief Financial Off ... | Sell | S | 5.00 | 16,927 | 84,635 | 769,616 | 786.5 K to 769.6 K (-2.15 %) |
| Aug 14 2012 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Sell | S | 4.25 | 55,000 | 233,750 | 235,208 | 290.2 K to 235.2 K (-18.95 %) |
| Dec 22 2011 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 350,000 | 0 | 1,349,151 | 999.2 K to 1.3 M (+35.03 %) |
| Dec 22 2011 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | Chief Financial Off ... | Grant | A | 0.00 | 250,000 | 0 | 786,543 | 536.5 K to 786.5 K (+46.59 %) |
| Dec 22 2011 | AISF | PLURISTEM THERAPEU ... | Pines Shai | Director | Grant | A | 0.00 | 50,000 | 0 | 209,708 | 159.7 K to 209.7 K (+31.31 %) |
| Dec 22 2011 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Grant | A | 0.00 | 85,000 | 0 | 290,208 | 205.2 K to 290.2 K (+41.42 %) |
| Dec 22 2011 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Grant | A | 0.00 | 90,000 | 0 | 287,208 | 197.2 K to 287.2 K (+45.64 %) |
| Dec 22 2011 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Grant | A | 0.00 | 85,000 | 0 | 292,708 | 207.7 K to 292.7 K (+40.92 %) |
| Dec 22 2011 | AISF | PLURISTEM THERAPEU ... | BRAUN ISAAC | Director | Grant | A | 0.00 | 50,000 | 0 | 215,208 | 165.2 K to 215.2 K (+30.26 %) |
| Dec 22 2011 | AISF | PLURISTEM THERAPEU ... | MERETZKI HAVA | Director | Grant | A | 0.00 | 50,000 | 0 | 215,208 | 165.2 K to 215.2 K (+30.26 %) |
| Dec 22 2011 | AISF | PLURISTEM THERAPEU ... | SHORRER DORON | Director | Grant | A | 0.00 | 125,000 | 0 | 337,208 | 212.2 K to 337.2 K (+58.90 %) |
| May 19 2011 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | Chief Financial Off ... | Grant | A | 0.00 | 150,000 | 0 | 536,543 | 386.5 K to 536.5 K (+38.81 %) |
| May 19 2011 | AISF | PLURISTEM THERAPEU ... | Pines Shai | Director | Grant | A | 0.00 | 42,860 | 0 | 159,708 | 116.8 K to 159.7 K (+36.68 %) |
| May 19 2011 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Grant | A | 0.00 | 42,860 | 0 | 205,208 | 162.3 K to 205.2 K (+26.40 %) |
| May 19 2011 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Grant | A | 0.00 | 42,860 | 0 | 197,208 | 154.3 K to 197.2 K (+27.77 %) |
| May 19 2011 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Grant | A | 0.00 | 42,860 | 0 | 207,708 | 164.8 K to 207.7 K (+26.00 %) |
| May 19 2011 | AISF | PLURISTEM THERAPEU ... | BRAUN ISAAC | Director | Grant | A | 0.00 | 42,860 | 0 | 165,208 | 122.3 K to 165.2 K (+35.03 %) |
| May 19 2011 | AISF | PLURISTEM THERAPEU ... | MERETZKI HAVA | Director | Grant | A | 0.00 | 42,860 | 0 | 165,208 | 122.3 K to 165.2 K (+35.03 %) |
| May 19 2011 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 150,000 | 0 | 999,151 | 849.2 K to 999.2 K (+17.66 %) |
| May 19 2011 | AISF | PLURISTEM THERAPEU ... | SHORRER DORON | Director | Grant | A | 0.00 | 42,860 | 0 | 212,208 | 169.3 K to 212.2 K (+25.31 %) |
| Jan 20 2011 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 3.20 | 25,000 | 80,000 | 849,151 | 874.2 K to 849.2 K (-2.86 %) |
| Jan 20 2011 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | Chief Financial Off ... | Sell | S | 3.20 | 15,000 | 48,000 | 386,543 | 401.5 K to 386.5 K (-3.74 %) |
| Jan 13 2011 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | Chief Financial Off ... | Sell | S | 2.60 | 10,000 | 26,000 | 401,543 | 411.5 K to 401.5 K (-2.43 %) |
| Jan 13 2011 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 2.60 | 25,000 | 65,000 | 874,151 | 899.2 K to 874.2 K (-2.78 %) |
| Dec 07 2010 | AISF | PLURISTEM THERAPEU ... | SHORRER DORON | Director | Buy | P | 1.40 | 7,000 | 9,800 | 169,348 | 162.3 K to 169.3 K (+4.31 %) |
| Nov 01 2010 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Grant | A | 0.00 | 40,000 | 0 | 154,348 | 114.3 K to 154.3 K (+34.98 %) |
| Nov 01 2010 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | Chief Financial Off ... | Grant | A | 0.00 | 80,000 | 0 | 411,543 | 331.5 K to 411.5 K (+24.13 %) |
| Nov 01 2010 | AISF | PLURISTEM THERAPEU ... | MERETZKI HAVA | Director | Grant | A | 0.00 | 40,000 | 0 | 122,348 | 82.3 K to 122.3 K (+48.57 %) |
| Nov 01 2010 | AISF | PLURISTEM THERAPEU ... | Pines Shai | Director | Grant | A | 0.00 | 40,000 | 0 | 116,848 | 76.8 K to 116.8 K (+52.05 %) |
| Nov 01 2010 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Grant | A | 0.00 | 80,000 | 0 | 164,848 | 84.8 K to 164.8 K (+94.29 %) |
| Nov 01 2010 | AISF | PLURISTEM THERAPEU ... | SHORRER DORON | Director | Grant | A | 0.00 | 80,000 | 0 | 162,348 | 82.3 K to 162.3 K (+97.15 %) |
| Nov 01 2010 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Grant | A | 0.00 | 80,000 | 0 | 162,348 | 82.3 K to 162.3 K (+97.15 %) |
| Nov 01 2010 | AISF | PLURISTEM THERAPEU ... | BRAUN ISAAC | Director | Grant | A | 0.00 | 40,000 | 0 | 122,348 | 82.3 K to 122.3 K (+48.57 %) |
| Nov 01 2010 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 160,000 | 0 | 899,151 | 739.2 K to 899.2 K (+21.65 %) |
| Aug 12 2010 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | Chief Financial Off ... | Grant | A | 0.00 | 70,000 | 0 | 331,543 | 261.5 K to 331.5 K (+26.76 %) |
| Aug 12 2010 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 200,000 | 0 | 739,151 | 539.2 K to 739.2 K (+37.10 %) |
| May 12 2010 | AISF | PLURISTEM THERAPEU ... | MERETZKI HAVA | Director | Grant | A | 0.00 | 3,648 | 0 | 82,348 | 78.7 K to 82.3 K (+4.64 %) |
| May 12 2010 | AISF | PLURISTEM THERAPEU ... | BRAUN ISAAC | Director | Grant | A | 0.00 | 3,648 | 0 | 82,348 | 78.7 K to 82.3 K (+4.64 %) |
| May 12 2010 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Grant | A | 0.00 | 3,648 | 0 | 84,848 | 81.2 K to 84.8 K (+4.49 %) |
| May 12 2010 | AISF | PLURISTEM THERAPEU ... | Pines Shai | Director | Grant | A | 0.00 | 3,648 | 0 | 76,848 | 73.2 K to 76.8 K (+4.98 %) |
| May 12 2010 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | CFO | Grant | A | 0.00 | 35,243 | 0 | 261,543 | 226.3 K to 261.5 K (+15.57 %) |
| May 12 2010 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Grant | A | 0.00 | 3,648 | 0 | 82,348 | 78.7 K to 82.3 K (+4.64 %) |
| May 12 2010 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Grant | A | 0.00 | 3,648 | 0 | 114,348 | 110.7 K to 114.3 K (+3.30 %) |
| May 12 2010 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 85,563 | 0 | 542,799 | 457.2 K to 542.8 K (+18.71 %) |
| May 12 2010 | AISF | PLURISTEM THERAPEU ... | SHORRER DORON | Director | Grant | A | 0.00 | 3,648 | 0 | 82,348 | 78.7 K to 82.3 K (+4.64 %) |
| Dec 29 2009 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Buy | P | 1.13 | 5,000 | 5,650 | 81,200 | 76.2 K to 81.2 K (+6.56 %) |
| Dec 29 2009 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Sell | S | 1.13 | 5,000 | 5,650 | 76,200 | 81.2 K to 76.2 K (-6.16 %) |
| Dec 24 2009 | AISF | PLURISTEM THERAPEU ... | BRAUN ISAAC | Director | Grant | A | 0.00 | 35,000 | 0 | 78,700 | 43.7 K to 78.7 K (+80.09 %) |
| Dec 24 2009 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Grant | A | 0.00 | 35,000 | 0 | 81,200 | 46.2 K to 81.2 K (+75.76 %) |
| Dec 24 2009 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Grant | A | 0.00 | 35,000 | 0 | 110,700 | 75.7 K to 110.7 K (+46.24 %) |
| Dec 24 2009 | AISF | PLURISTEM THERAPEU ... | MERETZKI HAVA | Director | Grant | A | 0.00 | 35,000 | 0 | 78,700 | 43.7 K to 78.7 K (+80.09 %) |
| Dec 24 2009 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Grant | A | 0.00 | 35,000 | 0 | 78,700 | 43.7 K to 78.7 K (+80.09 %) |
| Dec 24 2009 | AISF | PLURISTEM THERAPEU ... | Pines Shai | Director | Grant | A | 0.00 | 35,000 | 0 | 73,200 | 38.2 K to 73.2 K (+91.62 %) |
| Dec 24 2009 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | Chief Financial Off ... | Grant | A | 0.00 | 70,000 | 0 | 226,300 | 156.3 K to 226.3 K (+44.79 %) |
| Dec 24 2009 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 140,000 | 0 | 457,236 | 317.2 K to 457.2 K (+44.13 %) |
| Dec 24 2009 | AISF | PLURISTEM THERAPEU ... | SHORRER DORON | Director | Grant | A | 0.00 | 35,000 | 0 | 78,700 | 43.7 K to 78.7 K (+80.09 %) |
| May 13 2009 | AISF | PLURISTEM THERAPEU ... | Pines Shai | Director | Grant | A | 0.00 | 3,200 | 0 | 38,200 | 35 K to 38.2 K (+9.14 %) |
| May 13 2009 | AISF | PLURISTEM THERAPEU ... | YANAY YAKY | Chief Financial Off ... | Grant | A | 0.00 | 21,300 | 0 | 156,300 | 135 K to 156.3 K (+15.78 %) |
| May 13 2009 | AISF | PLURISTEM THERAPEU ... | ROSMAN NACHUM | Director | Grant | A | 0.00 | 3,200 | 0 | 43,700 | 40.5 K to 43.7 K (+7.90 %) |
| May 13 2009 | AISF | PLURISTEM THERAPEU ... | GERMAIN MARK | Director | Grant | A | 0.00 | 3,200 | 0 | 75,700 | 72.5 K to 75.7 K (+4.41 %) |
| May 13 2009 | AISF | PLURISTEM THERAPEU ... | BEN-YORAM ISRAEL | Director | Grant | A | 0.00 | 3,200 | 0 | 46,200 | 43 K to 46.2 K (+7.44 %) |
| May 13 2009 | AISF | PLURISTEM THERAPEU ... | BRAUN ISAAC | Director | Grant | A | 0.00 | 3,200 | 0 | 43,700 | 40.5 K to 43.7 K (+7.90 %) |
| May 13 2009 | AISF | PLURISTEM THERAPEU ... | MERETZKI HAVA | Director | Grant | A | 0.00 | 3,200 | 0 | 43,700 | 40.5 K to 43.7 K (+7.90 %) |
| May 13 2009 | AISF | PLURISTEM THERAPEU ... | SHORRER DORON | Director | Grant | A | 0.00 | 3,200 | 0 | 43,700 | 40.5 K to 43.7 K (+7.90 %) |
| May 13 2009 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 38,700 | 0 | 317,236 | 278.5 K to 317.2 K (+13.89 %) |